Last updated: 25 November 2019 at 4:30pm EST

Scott Dcdk Associates, L.L.... Net Worth




The estimated Net Worth of Scott Dcdk Associates, L.L.... is at least $2.81 Миллион dollars as of 21 November 2019. Scott L owns over 468,750 units of Molecular Templates Inc stock worth over $2,812,598 and over the last 6 years Scott sold MTEM stock worth over $0.

Scott L MTEM stock SEC Form 4 insiders trading

Scott has made over 2 trades of the Molecular Templates Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Scott bought 468,750 units of MTEM stock worth $3,750,000 on 21 November 2019.

The largest trade Scott's ever made was buying 545,454 units of Molecular Templates Inc stock on 25 September 2018 worth over $2,999,997. On average, Scott trades about 507,102 units every 211 days since 2018. As of 21 November 2019 Scott still owns at least 2,052,991 units of Molecular Templates Inc stock.

You can see the complete history of Scott L stock trades at the bottom of the page.



What's Scott L's mailing address?

Scott's mailing address filed with the SEC is 731 6th Ave BUILDING #2,C, New York, NY 10010, USA.

Insiders trading at Molecular Templates Inc

Over the last 7 years, insiders at Molecular Templates Inc have traded over $22,993,582 worth of Molecular Templates Inc stock and bought 14,744,530 units worth $82,519,716 . The most active insiders traders include Target N Vbb Biotech Ag Bio..., David Hirsch и Capital Partners Iii, Llc L.... On average, Molecular Templates Inc executives and independent directors trade stock every 47 days with the average trade being worth of $532,718. The most recent stock trade was executed by Target N Vbb Biotech Ag Bio... on 2 April 2024, trading 250,000 units of MTEM stock currently worth $587,500.



What does Molecular Templates Inc do?

molecular templates (mtem) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary engineered toxin body (etb) platform. mtem’s first immunotoxin, mt-3724, is in clinical development for non-hodgkin’s lymphoma. pipeline products for additional oncology targets are being advanced toward clinical development. for more information, please visit mtem’s website at www.mtem.com.



Complete history of Scott L stock trades at Molecular Templates Inc

инсайдер
Транзакция
Транзакция
Общая стоимость
Scott Dcdk Associates, L.L....
Купить $3,750,000
21 Nov 2019
Scott Dcdk Associates, L.L....
Купить $2,999,997
25 Sep 2018


Molecular Templates Inc executives and stock owners

Molecular Templates Inc executives and other stock owners filed with the SEC include: